Fact-checking
Fact-checked by Dr. Adam Kennah, MD on . See our fact-checking policy.
Every claim on GLP Agonists that affects a clinical decision, a financial decision, or a regulatory understanding is independently verified before publication. This page documents how.
Three classes of claim, each with a different verification standard:
Includes: drug names, dose ranges, indications, contraindications, drug-drug interactions, mechanism of action, FDA approval status, black-box warnings, common adverse effects.
Verifier: Dr. Adam Kennah, MD, with independent verification by Dr. John Berg, PharmD on claims concerning compounding or pharmacy operations.
Primary sources accepted: FDA-approved package inserts, FDA Drug Safety Communications, FDA Approved Drug Products (Orange Book), peer-reviewed clinical trials, USP General Chapters, state board of pharmacy disciplinary records.
Includes: provider list prices, intro rates, ongoing rates, annual totals, insurance coverage status, prior-authorization criteria, HSA/FSA eligibility.
Verifier: Maria Torres (Contributing Editor, Pricing).
Primary sources accepted: The provider's own patient-facing website on the date of citation, the carrier's published formulary, CMS public coverage policies, state Medicaid drug formularies.
Includes: FDA enforcement-discretion timelines, FDA shortage list status, FDA warning letters, state board actions, CMS coverage rule changes, HHS guidance.
Verifier: Amanda Chen (Lead Editor).
Primary sources accepted: Federal Register notices, FDA Guidance for Industry documents, FDA press releases, CMS National/Local Coverage Determinations, state board of pharmacy press releases.
Send the URL and the disputed claim to glpagonists@gmail.com. We acknowledge within seven business days and publish corrections (with a dated note on the page) within 14 business days when the claim cannot be defended against a primary source.
Last reviewed: May 20, 2026.